Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19.
Zysman M, Asselineau J, Saut O, Frison E, Oranger M, Maurac A, Charriot J, Achkir R, Regueme S, Klein E, Bommart S, Bourdin A, Dournes G, Casteigt J, Blum A, Ferretti G, Degano B, Thiébaut R, Chabot F, Berger P, Laurent F, Benlala I. Zysman M, et al. Among authors: chabot f. Eur Radiol. 2023 Dec;33(12):9262-9274. doi: 10.1007/s00330-023-09759-x. Epub 2023 Jul 5. Eur Radiol. 2023. PMID: 37405504 Free PMC article.
Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.
Cracowski JL, Chabot F, Labarère J, Faure P, Degano B, Schwebel C, Chaouat A, Reynaud-Gaubert M, Cracowski C, Sitbon O, Yaici A, Simonneau G, Humbert M. Cracowski JL, et al. Among authors: chabot f. Eur Respir J. 2014 Mar;43(3):915-7. doi: 10.1183/09031936.00151313. Epub 2013 Nov 14. Eur Respir J. 2014. PMID: 24232704 Free article. No abstract available.
[Impact of COPD: from disability to exacerbations].
Chabot F, Zysman M, Perrin J, Mercy M, Guillaumot A, Gomez E, Kheir A, Chaouat A. Chabot F, et al. Presse Med. 2014 Dec;43(12 Pt 1):1353-8. doi: 10.1016/j.lpm.2014.08.009. Epub 2014 Oct 29. Presse Med. 2014. PMID: 25448123 Review. French.
Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Société de Pneumologie de Langue Française.
Zysman M, Chabot F, Housset B, Morelot Panzini C, Devillier P, Roche N; Société de Pneumologie de Langue Française. Zysman M, et al. Among authors: chabot f. Eur Respir J. 2017 Oct 12;50(4):1701250. doi: 10.1183/13993003.01250-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29025880 Free article. No abstract available.
T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease.
Maurac A, Lardenois É, Eyries M, Ghigna MR, Petit I, Montani D, Guillaumot A, Caput B, Chabot F, Chaouat A. Maurac A, et al. Among authors: chabot f. Eur Respir J. 2019 Aug 22;54(2):1900388. doi: 10.1183/13993003.00388-2019. Print 2019 Aug. Eur Respir J. 2019. PMID: 31164435 Free article. No abstract available.
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
Valentin S, Maurac A, Sitbon O, Beurnier A, Gomez E, Guillaumot A, Textoris L, Fay R, Savale L, Jaïs X, Montani D, Picard F, Mornex JF, Prevot G, Chabot F, Humbert M, Chaouat A. Valentin S, et al. Among authors: chabot f. Eur Respir J. 2021 Nov 4;58(5):2004066. doi: 10.1183/13993003.04066-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 33875491 Free article.
[Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update].
Zysman M, Ribeiro Baptista B, Soumagne T, Marques da Silva V, Martin C, Thibault de Menonville C, Boyer L, Degano B, Morelot Panzini C, Burgel PR, Perez T, Bourdin A, Raherison C, Pégliasco H, Piperno D, Zanetti C, Morel H, Delclaux B, Delafosse C, Lorenzo A, Housset B, Chabot F, Devillier P, Deslée G, Roche N. Zysman M, et al. Among authors: chabot f. Rev Mal Respir. 2021 May;38(5):539-561. doi: 10.1016/j.rmr.2021.02.070. Epub 2021 May 10. Rev Mal Respir. 2021. PMID: 33985869 French. No abstract available.
170 results